Certainly, VivaBioCell means innovation.
Thanks to our unique and diversified expertise we are able to provide new tools overcoming the current state-of-the-art in cell culturing and advanced therapy manufacturing.
The evolution of automated cell expansion systems for mid- up to large-scale batch sizes. Maximum flexibility in cell expansion for clinical and commercial Advanced Therapies manufacturing needs.
Seamless transition from R&D to clinical and commercial manufacturing. Automated cell expansion and harvest. Small- to mid-scale batch sizes. Assuring product quality and minimizing costs. Easier cGMP translation and shorter time to market. Ideal for autologous products and redistributed scale-out manufacturing.
VivaBioCell at next ESSKA congress in Milan (6-9 May 2020)
For the first time, VivaBioCell will attend the ESSKA conference, taking place in Milan next 6-9 May: in this context we will be able to present our next-generation technologies and share our vision of making regenerative medicine a solution for common orthopaedic clinical challenges. Read more ›
VivaBioCell will attend next Advanced Therapies Congress & Expo 2020, in London (30 March – 1 April)
We will present our newly released NANT XL System, allowing to start ATMPs manufacturing from very small input material (e.g. 2 ml lipoaspirate, to produce up to 300 million MSCs). Read more ›
VivaBioCell is proud to be attending the event "Meet in Italy for Life Sciences 2019" in Trieste next 16-19th October
Come visit us at our booth and make sure to join our workshop taking place on 17th October at 9:30 (Sala 3) where we will shed lights on the A.R.T.E. Project (Advanced Regenerative Therapies Ecosystem). Read more ›